Literature DB >> 10221776

Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line.

M Shanmugam1, N L Krett, E T Maizels, R E Cutler, C A Peters, L M Smith, M L O'Brien, O K Park-Sarge, S T Rosen, M Hunzicker-Dunn.   

Abstract

We have previously shown that estrogen up-regulates expression of protein kinase C (PKC) delta in the rat and rabbit corpus luteum as well as in luteinized rat granulosa primary cell cultures. To determine whether a similar regulation of the PKC delta isoform by estrogen occurred in another estrogen responsive system, we investigated the estrogen receptor positive MCF-7 human breast cancer cells. In a characterization of PKC isoforms in MCF-7 cells we determined that PKC delta was the predominant PKC isoform. However in contrast to the effect of estrogen on PKC delta expression in ovarian cells, estrogen treatment of MCF-7 cells resulted in a significant decrease in PKC delta protein and mRNA expression in a time and dose dependent manner. Treatment of MCF-7 cells with 10(-10)-10(-8) M estrogen for 7 days down-regulated specifically PKC delta mRNA and protein while expression of other PKC isoforms was unchanged. The opposite regulation of PKC delta expression in ovarian and breast cancer cells prompted us to evaluate the type of estrogen receptor present in both cell types. Results showed that luteinized rat granulosa cells expressed predominantly estrogen receptor beta while the MCF-7 cells expressed predominantly estrogen receptor alpha and barely detectable levels of estrogen receptor beta. These results suggest that the differential ability of estrogen to regulate PKC beta expression could potentially be a result of differential signaling through the two estrogen receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221776     DOI: 10.1016/s0303-7207(98)00229-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.

Authors:  B Perillo; A Sasso; C Abbondanza; G Palumbo
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  The involvement of specific PKC isoenzymes in phorbol ester-mediated regulation of steroidogenic acute regulatory protein expression and steroid synthesis in mouse Leydig cells.

Authors:  Pulak R Manna; Jae-Won Soh; Douglas M Stocco
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

3.  Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.

Authors:  Caroline E Nunes-Xavier; Ari Elson; Rafael Pulido
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

4.  α2A-Adrenergic Receptor Activation Decreases Parabrachial Nucleus Excitatory Drive onto BNST CRF Neurons and Reduces Their Activity In Vivo.

Authors:  Tracy L Fetterly; Aakash Basu; Brett P Nabit; Elias Awad; Kellie M Williford; Samuel W Centanni; Robert T Matthews; Yuval Silberman; Danny G Winder
Journal:  J Neurosci       Date:  2018-11-26       Impact factor: 6.167

5.  Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death.

Authors:  Huajun Jin; Arthi Kanthasamy; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

6.  Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.

Authors:  Caroline E Nunes-Xavier; Céline Tárrega; Rocío Cejudo-Marín; Jeroen Frijhoff; Asa Sandin; Arne Ostman; Rafael Pulido
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

7.  Potentiation of genomic actions of estrogen by membrane actions in mcf-7 cells and the involvement of protein kinase C activation.

Authors:  Nino Devidze; Donald W Pfaff; Lee-Ming Kow
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.633

8.  Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.

Authors:  J W Assender; J M W Gee; I Lewis; I O Ellis; J F R Robertson; R I Nicholson
Journal:  J Clin Pathol       Date:  2007-11       Impact factor: 3.411

9.  PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens.

Authors:  Liqing Xiao; Anatilde Gonzalez-Guerrico; Marcelo G Kazanietz
Journal:  Mol Carcinog       Date:  2009-03       Impact factor: 4.784

10.  A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.

Authors:  Angelika Brekman; Kathryn E Singh; Alla Polotskaia; Nandini Kundu; Jill Bargonetti
Journal:  Breast Cancer Res       Date:  2011-01-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.